Your session is about to expire
← Back to Search
Neurotoxin
OLD (4 U per 0.1 mL) for Frown Lines
Phase < 1
Waitlist Available
Led By John Joseph, MD
Research Sponsored by Clinical Testing of Beverly Hills
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
At least 18 years of age at the time of signing the informed consent.
Overtly healthy as determined by medical evaluation (includes: medical history, physical examination, and vital signs).
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 270 days
Awards & highlights
Study Summary
This is a blinded, randomized study in the US to compare the duration response of two different concentrations of Jeuveau in healthy female subjects with moderate to severe dynamic glabellar lines on maximum frown.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 270 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~270 days
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Response Duration
Secondary outcome measures
Change from Baseline Score
Change in Frontalis Function
Investigator Live Assessment (At Rest)
+3 moreTrial Design
2Treatment groups
Active Control
Group I: OLD (4 U per 0.1 mL)Active Control1 Intervention
The total Jeuveau dose will be 20U divided into 5 injections. Each subject will receive a total of 0.5 mL of Jeuveau during the treatment.
Group II: COLD (4 U per 0.02 mL group)Active Control1 Intervention
The total Jeuveau dose will be 20U divided into 5 injections. Each injection will receive a total of 0.1 mL of Jeuveau during the treatment.
Find a Location
Who is running the clinical trial?
Clinical Testing of Beverly HillsLead Sponsor
3 Previous Clinical Trials
110 Total Patients Enrolled
Evolus, Inc.Industry Sponsor
7 Previous Clinical Trials
2,489 Total Patients Enrolled
John Joseph, MDPrincipal InvestigatorClinical Testing of Beverly Hills
6 Previous Clinical Trials
168 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Who else is applying?
How old are they?
18 - 65
What portion of applicants met pre-screening criteria?
Did not meet criteria
Share this study with friends
Copy Link
Messenger